Overall Technical outlook

Price Summary

Jubilant Pharmova Limited's stock spiked 3.18% today, marking a stellar performance in the market.
Jubilant Pharmova Limited's stock opened at 1060.5 on 2025-06-13, surged to a high of 1174.4, hit a low of 1060.0, and closed up 3.18% at 1094.2, with 6465244 shares traded.
The peak price for the stock in the past 52 weeks is 1254.55, with the lowest price being 720.05.

Technicals

Support and Resistance: The price for JUBLPHARMA is 1094.2, with support at 1061.6 and resistance at 1169.7. This suggests a range where 1061.6 acts as a base, preventing declines, and 1169.7 caps gains, defining key trading levels.
JUBLPHARMA supportResistance cc1e44
Support/Resistance for JUBLPHARMA


Aroon: AROON is currently indicating a strong bearish trend, with Aroon Down moving higher and the Aroon Oscillator remaining low. This combination suggests that the downward price trend is likely to persist. The continued low level of the Aroon Oscillator points to ongoing bearish momentum.
JUBLPHARMA aroon cc1e44
Aroon chart for Jubilant Pharmova Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral for JUBLPHARMA, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
JUBLPHARMA bbands cc1e44
Bolinger Bands chart for Jubilant Pharmova Limited


Parabolic SAR: The PSAR maintains a bearish stance, establishing a resistance level that could act as a barrier to any upward trends. This ongoing bearish outlook suggests that the market may continue to face resistance, keeping prices in check.
JUBLPHARMA psar cc1e44
Parabolic Stop and Reverse chart for Jubilant Pharmova Limited


Stochastic: The current state of the STOCHASTIC is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
JUBLPHARMA stoch cc1e44
Stochastic chart for Jubilant Pharmova Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages suggests a bearish trend, but the wavering slopes of the 20 and 50 SMAs hint at a potential shift. This weakening momentum could indicate that the bearish trend is running out of steam, possibly leading to a bullish reversal in the near future. Investors should be aware of the possibility of a market turnaround as the current downtrend begins to falter.
JUBLPHARMA trippleSMA cc1e44
Tripple SMA chart for Jubilant Pharmova Limited


When assessing a company's technical performance, such as stock price fluctuations and trading volume, it is crucial to first examine its fundamentals. These fundamentals include financial health, profitability, and growth potential. Additionally, understanding the industry's dynamics, including competitive pressures and market trends, is key to contextualizing the company's performance. By integrating these factors, a more comprehensive and meaningful analysis can be conducted, leading to more informed investment decisions.